The<unk>  was a clinical<unk>  that studied treatment of a birth defect called myelomeningocele, which is the most severe form of spina bifida. The study looked at prenatal (before birth) and postnatal (after birth) surgery to repair this defect. The first major phase concluded that prenatal surgery had strong, long-term benefits and some risks. The name of the<unk>  stands for Management of Myelomeningocele Study. It was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and was done by The Children's Hospital of Philadelphia, the University of California, San Francisco, Vanderbilt University Medical Center in Nashville and the George Washington University in Washington, D.C.
MOMS Trial
RECOVERY Trial
STEPS trial
Intersalt study
Solidarity trial
PLOS Clinical Trials
PRECEDE–PROCEED model
ASTEROID trial